These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10770143)

  • 1. Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by previous administration of plain polysaccharide vaccine?
    MacDonald NE; Halperin SA; Law BJ; Danzig LE; Granoff DM
    JAMA; 2000 Apr; 283(14):1826-7. PubMed ID: 10770143
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
    MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
    JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine.
    Richmond P; Kaczmarski E; Borrow R; Findlow J; Clark S; McCann R; Hill J; Barker M; Miller E
    J Infect Dis; 2000 Feb; 181(2):761-4. PubMed ID: 10669372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial.
    Lieberman JM; Chiu SS; Wong VK; Partidge S; Chang SJ; Chiu CY; Gheesling LL; Carlone GM; Ward JI
    JAMA; 1996 May; 275(19):1499-503. PubMed ID: 8622225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.
    Tunheim G; Arnemo M; Næss LM; Fjeldheim ÅK; Nome L; Bolstad K; Aase A; Mandiarote A; González H; González D; García L; Cardoso D; Norheim G; Rosenqvist E
    Vaccine; 2013 Dec; 31(51):6097-106. PubMed ID: 24120679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.
    Zhang Q; Lakshman R; Burkinshaw R; Choo S; Everard J; Akhtar S; Finn A
    Infect Immun; 2001 Jul; 69(7):4337-41. PubMed ID: 11401971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents.
    Zhang Q; Choo S; Everard J; Jennings R; Finn A
    Infect Immun; 2000 May; 68(5):2692-7. PubMed ID: 10768961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants.
    Twumasi PA; Kumah S; Leach A; O'Dempsey TJ; Ceesay SJ; Todd J; Broome CV; Carlone GM; Pais LB; Holder PK
    J Infect Dis; 1995 Mar; 171(3):632-8. PubMed ID: 7876610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial.
    MacLennan JM; Shackley F; Heath PT; Deeks JJ; Flamank C; Herbert M; Griffiths H; Hatzmann E; Goilav C; Moxon ER
    JAMA; 2000 Jun; 283(21):2795-801. PubMed ID: 10838647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MenACWY-TT vaccine for active immunization against invasive meningococcal disease.
    Papaevangelou V; Spyridis N
    Expert Rev Vaccines; 2012 May; 11(5):523-37. PubMed ID: 22827239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses to polysaccharides: lessons from humans and mice.
    González-Fernández A; Faro J; Fernández C
    Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera.
    Joseph H; Balmer P; Bybel M; Papa T; Ryall R; Borrow R
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):1-5. PubMed ID: 14715537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults.
    Anderson EL; Bowers T; Mink CM; Kennedy DJ; Belshe RB; Harakeh H; Pais L; Holder P; Carlone GM
    Infect Immun; 1994 Aug; 62(8):3391-5. PubMed ID: 8039909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal vaccine group C conjugate (Wyeth-Lederle).
    Drugs R D; 1999 Sep; 2(3):213-4. PubMed ID: 10641232
    [No Abstract]   [Full Text] [Related]  

  • 15. Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccine.
    de Whalley PC; Snape MD; Kelly DF; Banner C; Lewis S; Diggle L; John TM; Yu LM; Omar O; Borkowski A; Pollard AJ
    Pediatr Infect Dis J; 2011 Nov; 30(11):e203-8. PubMed ID: 21673612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A/C polysaccharide vaccine.
    Borrow R; Richmond P; Kaczmarski EB; Iverson A; Martin SL; Findlow J; Acuna M; Longworth E; O'Connor R; Paul J; Miller E
    FEMS Immunol Med Microbiol; 2000 May; 28(1):79-85. PubMed ID: 10767611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multivalent conjugate vaccine for prevention of meningococcal disease in infants.
    Harrison LH
    JAMA; 2008 Jan; 299(2):217-9. PubMed ID: 18182606
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinico-immunological characteristics in children given meningococcal group A polysaccharide vaccine developed at the G. N. Gabrichevskĭ Moscow Research Institute of Epidemiology and Microbiology].
    Skirda TA; Golovina LI; Mishina AI; Chernyshova TF; Savchenko LG; Chernyshova MS
    Pediatriia; 1992; (2):55-9. PubMed ID: 1513635
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination.
    Granoff DM; Gupta RK; Belshe RB; Anderson EL
    J Infect Dis; 1998 Sep; 178(3):870-4. PubMed ID: 9728562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.